August 26, 2020
„The depth of the information contained in the IndivuType database is outstanding. Together with its AI-integrated advanced analytics platform it is a game-changer for drug discovery and development programs and we are excited about the opportunity to work with Indivumed.“
IndivuType, the multi-omics cancer database, is utilized by pharma and biotech companies to accelerate oncology drug discovery and development programs.
IndivuType’s AI-integrated data analytics platform provides novel target and biomarker insights in a fast, convenient and reliable way through its unique integration of genome, transcriptome, proteome, phospho-proteome, clinical and follow up information.
Together, and through our rapidly growing clinical partner network, IndivuType will support clinical trials by comprehensive patient stratification in all main regions of the world.